Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Schuetze

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Opinion in Oncology|May 25, 2006
Utility of positron emission tomography in sarcomasScott M Schuetze
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Chemotherapy in the management of osteosarcoma and Ewing's sarcomaScott M Schuetze
Hematology/Oncology Clinics of North America|June 9, 2005
Imaging and response in soft tissue sarcomasScott M Schuetze
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years LaterScott M Schuetze
The Oncologist|October 8, 2009
Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?Scott M Schuetze, Shreyaskumar Patel
Current Opinion in Oncology|April 19, 2012
Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial resultsBinu Malhotra, Scott M Schuetze
JAMA Oncology|September 18, 2015
Aldoxorubicin in Sarcoma: Teaching an Old Drug New TricksRashmi Chugh, Scott M Schuetze
Current Opinion in Oncology|June 6, 2008
New targets for therapy of sarcomaJohn M Magenau, Scott M Schuetze
Current Treatment Options in Oncology|May 22, 2012
Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumorsAnn W Silk, Scott M Schuetze
Current Oncology Reports|January 27, 2007
Targeted therapy for dermatofibrosarcoma protuberansThomas A Abrams, Scott M Schuetze
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Opinion in Oncology|May 25, 2006
Utility of positron emission tomography in sarcomasScott M Schuetze
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Chemotherapy in the management of osteosarcoma and Ewing's sarcomaScott M Schuetze
Hematology/Oncology Clinics of North America|June 9, 2005
Imaging and response in soft tissue sarcomasScott M Schuetze
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years LaterScott M Schuetze
The Oncologist|October 8, 2009
Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?Scott M Schuetze, Shreyaskumar Patel
Current Opinion in Oncology|April 19, 2012
Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial resultsBinu Malhotra, Scott M Schuetze
JAMA Oncology|September 18, 2015
Aldoxorubicin in Sarcoma: Teaching an Old Drug New TricksRashmi Chugh, Scott M Schuetze
Current Opinion in Oncology|June 6, 2008
New targets for therapy of sarcomaJohn M Magenau, Scott M Schuetze
Current Treatment Options in Oncology|May 22, 2012
Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumorsAnn W Silk, Scott M Schuetze
Current Oncology Reports|January 27, 2007
Targeted therapy for dermatofibrosarcoma protuberansThomas A Abrams, Scott M Schuetze
Pageof 8